Excision gives first look at gene editing therapy for HIV

Data from the first three participants enrolled in the study showed the CRISPR-based treatment to be safe, Excision said.Dive Brief:A gene editing treatment for HIV was safely given to the first three adults enrolled in a small clinical trial, the therapy’s developer, Excision BioTherapeutics, said Wednesday.Initial results from the study, presented at the European Society […]